CHEMGRID MOLECULE CARD
PIMOZIDE
PIMOZIDE in ChemGrid: 205 screened assays, 18 with significant responses. Explore chemical identifiers, strain activity and target evidence.
SPE01501134
Explore activity & SONAR
Identity and chemistry
- ChemGrid identifier
- SPE01501134
- Molecular formula
- C28F2H29N3O
- CAS registry number
- 2062-78-4
- InChIKey
- YVUQSNJEYSNKRX-UHFFFAOYSA-N
- Libraries
- Spectrum, SPECMTS3, Spectrum_ED
- Other recorded names
- Pimozide
Stored SMILES
Fc1ccc(cc1)C(CCCN1CCC(CC1)N1C(=O)Nc2ccccc12)c1ccc(F)cc1Matched external records: PubChem 16362
Chemical identifiers and library names are reproduced from ChemGrid records. Missing values are omitted.
Measured chemical–genetic activity
205 measurements across 205 distinct library–species–strain assays; 18 assays have at least one significant response (|Z| ≥ 4, p ≤ 0.001, excluding flagged outliers).
Responses are indirect screening phenotypes. They do not establish that a strain gene is a direct molecular target. Strains and timepoints are retained as recorded; these counts are not counts of unique ORFs.
| Strain | Library | Species identifier | Z-score |
|---|---|---|---|
| MT2481-pdr1pdr3-2nd | SPECMTS3 | 4932 | -16.17 |
| snf2 | SPECMTS3 | 4932 | -11.01 |
| vph1 | SPECMTS3 | 4932 | -9.96 |
| rvs167 | Spectrum | 4932 | -9.04 |
| spo22 | Spectrum | 4932 | 8.83 |
| bem2 | SPECMTS3 | 4932 | -8.61 |
| mms22 | SPECMTS3 | 4932 | -7.06 |
| ccr4 | SPECMTS3 | 4932 | -6.87 |
| rgp1 | SPECMTS3 | 4932 | 6.82 |
| rrp6 | SPECMTS3 | 4932 | -6.71 |
| doa4 | SPECMTS3 | 4932 | -5.78 |
| spt3 | SPECMTS3 | 4932 | -5.58 |
Spectrum compound-combination identifiers are excluded from this short table. The interactive profile retains the full measurements.
Recorded target evidence and yeast matches
Source annotations are shown separately from SONAR hypotheses. Evidence type and identity matching can vary; consult the linked source and interactive evidence panel.
| Target | Source | Yeast ORF / orthologue |
|---|---|---|
| CACNA1G · Voltage-dependent T-type calcium channel subunit alpha-1G | ChEMBL | No stored yeast mapping |
| DRD2 · D(2) dopamine receptor | ChEMBL | No stored yeast mapping |
| DRD3 · D(3) dopamine receptor | ChEMBL | No stored yeast mapping |
| Drd5 · Dopamine receptor | ChEMBL | No stored yeast mapping |
| HTR2A · 5-hydroxytryptamine receptor 2A | ChEMBL | No stored yeast mapping |
| HTR2B · Serotonin 2 (5-HT2) receptor | ChEMBL | No stored yeast mapping |
| Htr7 · 5-hydroxytryptamine receptor 7 | ChEMBL | No stored yeast mapping |
| Impa1 · Inositol monophosphatase 1 | ChEMBL | No stored yeast mapping |
| KCNH2 · Voltage-gated inwardly rectifying potassium channel KCNH2 | ChEMBL | No stored yeast mapping |
| MAPK1 · Mitogen-activated protein kinase 1 | ChEMBL | SLT2 YHR030C (ortholog_many2many); YKL161C (ortholog_many2many) |
| SCN1A · Sodium channel alpha subunit | ChEMBL | No stored yeast mapping |
| CACNA1G · Voltage-dependent T-type calcium channel subunit alpha-1G | ChEMBL analogue | No stored yeast mapping |
| DRD2 · D(2) dopamine receptor | ChEMBL analogue | No stored yeast mapping |
| DRD3 · D(3) dopamine receptor | ChEMBL analogue | No stored yeast mapping |
| Drd5 · Dopamine receptor | ChEMBL analogue | No stored yeast mapping |
| HTR2A · 5-hydroxytryptamine receptor 2A | ChEMBL analogue | No stored yeast mapping |
| HTR2B · Serotonin 2 (5-HT2) receptor | ChEMBL analogue | No stored yeast mapping |
| Htr7 · 5-hydroxytryptamine receptor 7 | ChEMBL analogue | No stored yeast mapping |
| Impa1 · Inositol monophosphatase 1 | ChEMBL analogue | No stored yeast mapping |
| KCNH2 · Voltage-gated inwardly rectifying potassium channel KCNH2 | ChEMBL analogue | No stored yeast mapping |
| MAPK1 · Mitogen-activated protein kinase 1 | ChEMBL analogue | SLT2 YHR030C (ortholog_many2many); YKL161C (ortholog_many2many) |
| SCN1A · Sodium channel alpha subunit | ChEMBL analogue | No stored yeast mapping |
Structural activity predictions and SONAR
Stored structural activity predictions are available in the interactive profile, with assay-specific cutoffs and applicability-domain assessments.
SONAR ranks candidate targets through genetic and physical interaction evidence. Structural SONAR uses predicted strain responses; measured SONAR uses experimental responses. These are experimental hypotheses, not confirmed binding targets. Outside-domain predictions are treated as unknown.
Open the complete PIMOZIDE research profile →Sources and provenance
Screening measurements: ChemGrid chemical-genetic datasets. Wildenhain et al., Cell Systems (2015). Target annotations: sources named in the evidence table. Structure and library metadata: stored ChemGrid catalogue records.
Card snapshot: 2026-11-02. Linked interactive views may contain newer data.